Archives de l’auteur : oxeltis
Oxeltis will be at Bio Japan (Yokohama, October 10-12, 2018). We will be happy to meet you to discuss your current and future projects involving: – medicinal chemistry (Hit selection & optimization, SAR analysis, Hit-to-lead work, Lead optimization, FTEs…) – and small molecule custom synthesis (heterocycles, macrocycles, nucleos(t)ides, … Continuer la lecture
Meet Oxeltis at EFMC International Symposium on Medicinal Chemistry in Ljubljana – Slovenia, Sept 2-6, 2018
Oxeltis is happy to meet you at the International Round Table in La Jolla – CA – USA, August 26-30, 2018 to discuss your current and future projects involving nucleoside chemistry. Oxeltis is known for – Several references in antiviral … Continuer la lecture
Oxeltis is pleased to take part to the AFSSI annual meeting on preclinical research on July 3rd, in Marseille. Come and join us to talk about your current or future fine chemistry and medicinal chemistry projects.
Oxeltis is present at BIO International Convention in Boston (MA), USA ! We look forward to seeing you there. For any appointments you can check our profile on One on One Partnering or send us an email : email@example.com.
Oxeltis is at Meet2Win, Oncology business convention in Bordeaux, May 17-18. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L work, Lead optimization…) and small molecule custom synthesis. See you … Continuer la lecture
Oxeltis will be present at OncoWeek Toulouse, looking forward meeting you firstname.lastname@example.org